Epidemiology of HR+/HER2- Breast Cancer HR+/HER2- breast cancer is the most prevalent subtype, accounting for nearly 70% of all breast cancer cases. Defined by hormone receptor (HR) positivity and the absence of HER2 overexpression, its incidence varies worldwide, with higher detection rates in developed regions due to advanced screening and diagn